By Anne C. Roberts, MD
CODING & REIMBURSEMENT
A perspective on the CMS decision memo regarding CAS.
By Kieran P. Murphy, MD
This technique may provide a more cost-effective and patient-specific option.
By John H. Rundback, MD
Recent developments in technology have made primary stenting an attractive option.
By Gary M. Ansel, MD
Current available data suggest that an adjustment may be necessary.
By Dierk Scheinert, MD
Optimal use of today’s imaging options combined with an elevated index ofsuspicion enables results in early detection and successful treatment.
By Michael R. Jaff, DO
Two devices are currently being evaluated for treating patients with iliac aneurysmal disease.
By Zvonimir Krajcer, MD
When is surgery still the best option for aortoiliac occlusive disease?
By David H. Stone, MD, and Richard P. Cambria, MD
An iliac is not an iliac is not an iliac.
By Roseanne R. Wholey
An overview of the complications associated with treating iliac arteries.
By M. Habeeb Ahmed, MD, RVT; Aravinda Nanjundappa, MD; and John R. Laird, Jr, MD
Clarification of the FDA definition of custom devices.
By Dorothy B. Abel, with Harold Pellerite
An incorrectly placed filter is retrieved before it migrates to the heart.
By Eyal Barzel, MD, and James McGuckin, MD
By John R. Laird, Jr, MD
An update of the history and future of the Peripheral Vascular Surgery Society.
By Lewis B. Schwartz, MD, and Robert G. Scribner, MD
Results from the APPROVE trial and the emerging role of “endopharmacology” in treating PVD.